<?xml version="1.0" encoding="UTF-8"?>
<p>An extract of 
 <italic>Agaricus blazei</italic> Murrill Kyowa, known to have antimutagenic and antitumor properties, was used in a randomized clinical trial (RCT) of 100 patients suffering from various gynecological cancers (cervical, ovarian, and endometrial) and receiving chemotherapy [
 <xref rid="B67-ijms-22-00634" ref-type="bibr">67</xref>]. The treated group showed increased NK cell activity, while no significant differences were found in lymphokine-activated killer and monocyte activities. Furthermore, administration of the fungal extract resulted in a clear reduction in chemotherapy-related side effects, such as loss of appetite, alopecia, emotional instability, and general weakness, as well as a marked improvement in mood-related parameters (anxiety, depression, mental stability).
</p>
